UA110789C2 - An antibody reactive regard b7-h3, an immunologically active fragment thereof and their use - Google Patents

An antibody reactive regard b7-h3, an immunologically active fragment thereof and their use

Info

Publication number
UA110789C2
UA110789C2 UAA201211339A UAA201211339A UA110789C2 UA 110789 C2 UA110789 C2 UA 110789C2 UA A201211339 A UAA201211339 A UA A201211339A UA A201211339 A UAA201211339 A UA A201211339A UA 110789 C2 UA110789 C2 UA 110789C2
Authority
UA
Ukraine
Prior art keywords
regard
active fragment
immunologically active
antibody reactive
antibody
Prior art date
Application number
UAA201211339A
Other languages
Ukrainian (uk)
Inventor
Дерік Т. Лу
Лін Хуан
Пол А. Мур
Франсін Чжіфень Чень
Леслі С. Джонсон
Original Assignee
Макродженікс, Інк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Макродженікс, Інк. filed Critical Макродженікс, Інк.
Priority claimed from PCT/US2011/026689 external-priority patent/WO2011109400A2/en
Publication of UA110789C2 publication Critical patent/UA110789C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Винахід належить до В7-Н3 зв’язувальних антитіл та їх фрагментів або діатіл, застосування вказаних антитіл для діагностики раку, фармацевтичної композиції, що містить вказане антитіло та застосування антитіла або фармацевтичної композиції для одержання лікарського засобу для лікування раку.The invention relates to B7-H3 binding antibodies and their fragments or diabodies, the use of said antibodies for cancer diagnosis, a pharmaceutical composition containing said antibody, and the use of an antibody or pharmaceutical composition for the preparation of a medicament for the treatment of cancer.

UAA201211339A 2010-03-04 2011-01-03 An antibody reactive regard b7-h3, an immunologically active fragment thereof and their use UA110789C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31069210P 2010-03-04 2010-03-04
PCT/US2011/026689 WO2011109400A2 (en) 2010-03-04 2011-03-01 Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof

Publications (1)

Publication Number Publication Date
UA110789C2 true UA110789C2 (en) 2016-02-25

Family

ID=55700620

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201211339A UA110789C2 (en) 2010-03-04 2011-01-03 An antibody reactive regard b7-h3, an immunologically active fragment thereof and their use

Country Status (2)

Country Link
AR (1) AR122392A2 (en)
UA (1) UA110789C2 (en)

Also Published As

Publication number Publication date
AR122392A2 (en) 2022-09-07

Similar Documents

Publication Publication Date Title
CY1122490T1 (en) ANTIBODIES TO HUMAN CD38
CY1121392T1 (en) COMBINATION MOLECULES AGAINST ALPHA-SYNUCLEIN
CY1121538T1 (en) MONOCLONIC ANTIBODIES AGAINST TISSUE FACTOR INHIBITOR (TFPI)
ECSP12012272A (en) PROTEINS THAT JOIN TNF-?
MX369148B (en) Kir3dl2 binding agents.
TN2015000396A1 (en) Antibody drug conjugates
UA115439C2 (en) Humanized antibodies that recognize alpha-synuclein
UA116772C2 (en) Cd47 antibodies and methods of use thereof
UA109633C2 (en) HUMAN ANTIBODY AGAINST TISSUE FACTOR
EP3539988A3 (en) Monoclonal antibodies against her2
MX340295B (en) Monoclonal antibodies against c-met.
MX2018010331A (en) Vegf/dll4 binding agents and uses thereof.
MX2015012122A (en) Antibody drug conjugates and corresponding antibodies.
CY1119410T1 (en) OPTIMIZED monoclonal antibodies against the TFPI inhibitor (TFPI)
IL212633A (en) Monoclonal antibody or antigen-binding fragment thereof, pharmaceutical compositions comprising the same and use thereof for the manufacture of medicaments for the treatment of cancer
MA34091B1 (en) Antibody antibody cd40
MX347893B (en) Human antibody drug conjugates against tissue factor.
NZ703481A (en) Cd37-binding molecules and immunoconjugates thereof
MX341076B (en) Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments.
MX350200B (en) Human antibodies and antibody-drug conjugates against cd74.
MX2018015915A (en) Specific binding proteins and uses thereof.
EA201270769A1 (en) ANTIBODIES TO CGRP
TN2012000466A1 (en) Humanized anti cxcr4 antibodies for the treatment of cancer
EP2579895A4 (en) Anti-vegf antibodies and uses thereof
TR201903026T4 (en) S100A4 ANTIBODIES AND THEIR THERAPEUTIC USES.